Lunai Bioworks Inc. Operating Lease Right-of-Use Assets
Lunai Bioworks Inc. (LNAI) had Operating Lease Right-of-Use Assets of $687.37 thousand as of 2025-06-30, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-05-15
- 2025-06-30: Operating Lease, Right-of-Use Asset $687.37K.
- 2025-03-31: Operating Lease, Right-of-Use Asset $992.36K.
- 2024-12-31: Operating Lease, Right-of-Use Asset $1.18M.
- 2024-09-30: Operating Lease, Right-of-Use Asset $1.15M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2025-06-30 | $687.37K 10-Q · filed 2026-05-15 | |
| 2025-03-31 | $992.36K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.18M 10-Q · filed 2025-02-19 | |
| 2024-09-30 | $1.15M 10-Q/A · filed 2025-02-19 | |
| 2024-06-30 | $1.27M 10-K · filed 2025-09-29 | |
| 2024-03-31 | $1.39M 10-Q/A · filed 2025-02-19 | |
| 2023-12-31 | $812.69K 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $863.60K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $913.99K 10-Q/A · filed 2025-02-19 | |
| 2023-03-31 | $963.87K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $1.01M 10-Q · filed 2023-03-09 | |
| 2022-09-30 | $1.06M 10-Q · filed 2023-03-07 | |
| 2022-06-30 | $1.16M 10-K · filed 2023-10-02 | |
| 2022-03-31 | $1.23M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.30M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $1.37M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.44M 10-K · filed 2023-02-27 | |
| 2021-03-31 | $1.50M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.57M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $1.64M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.70M 10-K · filed 2021-09-24 | |
| 2020-03-31 | $1.77M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.83M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $1.99M 10-Q · filed 2019-11-13 | |
| 2019-07-02 | $1.96M 10-Q · filed 2020-05-11 | $2.05M 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |